About the Covid-19 vaccination programme
According to plan, Sweden's Covid-19 vaccination programme could begin as early as January 2021.
Covid-19 vaccination begins on 27 December
On 27 December, vaccination against Covid-19 will begin in retirement homes in Sweden. The first shipment, with 9750 doses, will be distributed to all regions of the country.
Extra vaccine dose for immunodeficiency
The Public Health Agency recommends an extra dose of COVID-19 vaccine for those with a severely compromised immune system. The recommendation applies from 1 September.
Young people will be offered the Covid 19 vaccine in August
The Public Health Authority has stated that young people born in 2005 or before will be offered the Covid 19 vaccine from week 32 (August 9th) onwards.
Adapted restrictions to be introduced 1 June
The spread of infection remains at a high level in Sweden. The date on which adaptations of restrictions and prohibitions may come into force has therefore been postponed until 1...
The Public Health Agency is calling for working remotely
The Public Health Agency of Sweden encourages employers in the Stockholm region to allow employees to work from home whenever possible.
The Public Health Agency of Sweden recommends remote learning
The Public Health Agency of Sweden recommends that Sweden's upper secondary schools, municipal adult education, university colleges and universities implement remote learning due...
The Public Health Agency of Sweden: Persons over the age of 70 should limit their social contacts
The Public Health Agency of Sweden (Folkhälsomyndigheten) is urging persons over the age of 70 to limit their contacts with other people as far as possible for some time to come.
Travellers from Brazil urged to get tested and avoid contact with others
The Public Health Agency of Sweden recommends that people who have been to Brazil and travelled into Sweden get tested for Covid-19 and avoid contact with others.
Moderna vaccine covered by pharmaceutical insurance scheme
A new agreement has been signed that means the state will bear the cost of any adverse effects of the Moderna COVID-19 vaccine.